National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Study of Tamoxifen and Raloxifene (STAR) Trial
    Posted: 07/27/2000    Updated: 09/12/2007
Related Pages
Breast Cancer Home Page 1
NCI's gateway for information about breast cancer.

U.S. Task Force: Chemoprevention of Breast Cancer 2
The U.S. Preventive Services Task Force has issued two recommendations concerning the use of prescription medicines such as tamoxifen in the prevention of breast cancer.

Estrogen Receptors, Tamoxifen, and Raloxifene 3
Describes the hormone estrogen and its receptor. Explains the relationship of estrogen and its receptor to breast cancer and the risks and benefits of reducing cancer risk with drugs called antiestrogens and selective estrogen receptor molecules (SERMs).
STAR Images

The National Surgical Adjuvant Breast and Bowel Project (NSABP) maintains a Web site with information about STAR, including a STAR Image Gallery 4.



Table of Links

1http://www.cancer.gov/cancertopics/types/breast
2http://redir.nci.nih.gov/cgi-bin/redir.pl?section=Clinicaltrials&destURI=http%3
a%2f%2fwww.ahrq.gov%2fclinic%2f3rduspstf%2fbreastchemo%2f
3http://www.cancer.gov/cancertopics/understandingcancer/estrogenreceptors
4http://www.nsabp.pitt.edu/STAR/STAR_Image_Gallery.htm